250+ investors that invest in your industry and stage
Marketplace
Gaming
Community
Proptech
Biotech
Impact
Health Care
FinTech
Energy
Artificial intelligence
Google
Consumer
Climate
Hardware
EdTech
Venture Capital
Sustainability
Real Estate
Finance
Retail
Digital Media
Web3
Video Games
Music
Publishing
Beauty
Education
Android
B2B
Payments
Organic Food
Infrastructure
Franchise
Food and Beverage
Financial Services
Construction
Photography
Clean Energy
Enterprise Software
Big Data
Biotechnology
Platforms
Sports
Cannabis
Fitness
Travel
Manufacturing
Recruiting
Mobile Advertising
Hospitality
Email
Automotive
Crowdfunding
Social
Internet
Medical Device
Wine And Spirits
Social Media
CleanTech
Mobile Apps
Transportation
Social Network
InsurTech
Enterprise
Local
Wellness
LGBT
Medical
Art
Legal
Mobile
Fashion
Oil and Gas
eSports
Non Profit
Theatre
Film
Life Science
SaaS
Renewable Energy
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
United Kingdom
United States
Germany
India
Australia
Canada
New Zealand
South Korea
Ireland
Saudi Arabia
Brazil
Armenia
Qatar
Asia
Sri Lanka
Europe
Spain
South Africa
Vietnam
Japan
Singapore
Belgium
Hungary
Middle East
Faroe Islands
Belarus
Bahrain
Gibraltar
France
LATAM
Barbados
Greece
China
Belize
Hong Kong
Algeria
Africa
Ghana
Finland
Oceania
Czech Republic
Estonia
Indonesia
Croatia
Bermuda
Chile
Liberia
Costa Rica
Kuwait
Georgia
Ecuador
Bulgaria
Philippines
Denmark
Ethiopia
Egypt
Ukraine
Malaysia
Turkey
Serbia
Sierra Leone
Morocco
Rwanda
Venezuela
Sweden
Senegal
Peru
Tajikistan
Puerto Rico
Portugal
Nicaragua
Uganda
Taiwan
Malta
Slovenia
Togo
Russian Federation
Mexico
Tanzania
Zimbabwe
San Marino
Uruguay
Lithuania
Poland
El Salvador
Thailand
Lebanon
Tunisia
Jersey
Zambia
Myanmar
Uzbekistan
Dominican Republic
Mali
Liechtenstein
Bahamas
Namibia
Azerbaijan
Iceland
Israel
Nigeria
Iraq
United Arab Emirates
Jamaica
Panama
Honduras
Bolivia
Isle of Man
Mozambique
Luxembourg
Italy
Albania
Pakistan
Mauritius
Norway
Grenada
Jordan
Romania
Argentina
Kenya
Bangladesh
Kazakhstan
Cayman Islands
Cambodia
Austria
Cyprus
Oman
Latvia
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Seychelles
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Life Science Angel Investors in Europe in May 2026

A list of 50 angel investors that invest in Life science startups based in Europe. We rank investors based on the number of investments they made in Life science companies from Europe. We update this investor list every month.

Top 50 Life Science Angel Investors in Europe in May 2026

Investor Life Science Europe investments
Jonathan Milner 9
Nadav Rosenberg 4
Jeff Dean 3
Andrew Keys 3
Stefano Bernardi 3
Ian Hogarth 2
Luc Vauterin 2
Sauli Törmälä 2
Darrin Disley 2
Bradley Horowitz 2
Albert Wenger 2
Andrew Nutter 2
Nicholas Edwards 2
Thor Bjorgolfsson 2
Mati Staniszewski 2
Aidan Gomez 2
Michael Novogratz 2
Annie Vereecken 2
Robert Kopple 2
Jan Hruska 2
David Helgason 2
Carsten Maschmeyer 2
Ed Parkinson 2
Pierre Drion 2
Nico Wittenborn 2
Leena Niemistö 2
Mark Evans 2
Damien Lane 2
Jude Gomila 2
Holger Hübner 2
Sylvain Zimmer 2
Bas Godska 1
Nikolaus Sturm 1
Christophe Ricard 1
Virginie Saverys 1
Jens Mogensen 1
Mariliis Holm 1
Steen Riisgaard 1
Jon Oringer 1
Nadav Ben-Chanoch 1
Griet Nuytinck 1
John Bethell 1
Jacques Lewiner 1
Ritu Bansal-Mutalik 1
Maximilien Levesque 1
Naheed Kurji 1
Simon Galbraith 1
Toni Kroos 1
Josefin Landgård 1
Alfons Hidalgo 1

Reach every investor

Get a list of investors who already back your industry, stage, and country. Emails & phones included.

Find investors — It's Free!
Investor list
Jonathan Milner
Angel · Cambridge, Massachusetts, United States

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Spain

Portfolio highlights

  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Biotechnology, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • United Kingdom, France, Israel

Portfolio highlights

  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Artificial Intelligence, Information Technology, Software
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Japan

Portfolio highlights

  • RunSybil — RunSybil is an AI-driven offensive security platform that continuously evaluates applications and infrastructure for vulnerabilities. Leveraging cutting-edge AI techniques, it autonomously identifies and exploits real-world security flaws through sophisticated penetration testing. By automating hacker-like intuition, RunSybil delivers proactivedefense capabilities, empowering organizations to strengthen the security of modern applications.
  • Meshcapade — Foundation models that teach AI to see, understand, and move.
  • Supermemory — Supermemory offers a platform for organizing and retrieving saved knowledge through a combination of memory APIs, semantic search, and integrated tools. It enables users and developers to import content from documents, bookmarks, and external services, and then query that content using natural language. Supermemory supports workflows like building“second brain” systems, intelligent agents, and knowledge bases by connecting context across documents. It provides permission controls and integration with large language models to allow applications to maintain stateful, evolving memory. Supermemory also addresses use-cases in research, content writing, support systems, and enterprise knowledge management.
Show all investments...

Andrew Keys
Angel

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Software, Finance, Blockchain
  • Seed, Pre-Seed, Series A
  • United States, India, Norway

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Software, Biotechnology, CleanTech
  • Seed, Pre-Seed, Funding Round
  • Italy, United Kingdom, France

Portfolio highlights

  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
  • Kresko Labs — Join the Quest for accessible wealth with Kresko, a synthetic asset protocol. Explore innovative possibilities now.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Show more...

Investment focus

  • Software, E-Commerce, Medical
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Germany

Portfolio highlights

  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Show all investments...

Luc Vauterin
Angel

Luc Vauterin - Board Member @ ONTOFORCE

Show more...

Investment focus

  • Life Science, Data Integration, Data Visualization
  • Seed, Series A
  • Belgium

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Sauli Törmälä
Angel · Helsinki, Southern Finland, Finland

Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.

Show more...

Investment focus

  • Life Science, Biotechnology
  • Seed
  • Finland

Portfolio highlights

  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Biotechnology, Health Care, Big Data
  • Seed, Series A, Funding Round
  • United Kingdom

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Germany

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • Opal — Making it better at capturing incredible low-light video. Even in dimly lit room, you’ll get a level of detail and color that wasn’t possible before.The Opal C1 comes with MicMesh™, an array of beamforming microphones that find and focus on the sound of your voice. And with intelligent noise cancellation, every ding, drop and dog bark is filteredout to get an audio experience that clearly speaks for itself.
  • Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
Show all investments...

Albert Wenger
Angel · New York, New York, United States

Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.

Show more...

Investment focus

  • Software, Manufacturing, Internet
  • Series A, Series B, Seed
  • United States, Germany, Switzerland

Portfolio highlights

  • DiviGas — DiviGas is an oil and gas company that developed a new process for manufacturing membranes which has yielded vastly superior results to what a membrane can do. The company was founded in 2019 and headquartered in Central Region, Singapore.
  • Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
  • Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Software, SaaS, FinTech
  • Seed, Pre-Seed, Funding Round
  • France, United Kingdom, United States

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants
  • Jump — Jump takes the hassle out of being a freelancer. We accompany hundreds of freelancers in their daily lives by securing their adventure. Relax, we take care of everything.
  • Core Biogenesis — Biodesigning the Future of Regenerative Medicine & Skincare
Show all investments...

Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Thor Bjorgolfsson
Angel · London, England, United Kingdom

Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.

Show more...

Investment focus

  • Big Data, TV, B2B
  • Seed, Series A, Series C
  • United Kingdom, Germany

Portfolio highlights

  • Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Show all investments...

Mati Staniszewski
Angel · London, England, United Kingdom

Mati Staniszewski is the Co-Founder of ElevenLabs.

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed
  • United States

Portfolio highlights

  • VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
  • SalesPatriot — We deploy AI into supply chains that the West depends on.
  • Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Show all investments...

Aidan Gomez
Angel · Oxford, Arkansas, United States

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Show more...

Investment focus

  • Artificial Intelligence, Software, Information Technology
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Canada

Portfolio highlights

  • Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
  • Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!
Show all investments...

Michael Novogratz
Angel · New York, New York, United States

Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.

Show more...

Investment focus

  • Blockchain, Cryptocurrency, FinTech
  • Seed, Funding Round, Series A
  • United States, India, Germany

Portfolio highlights

  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • CryptoQuant — CryptoQuant is a community-driven analytics platform to lower hurdles of data-based decisions. Crypto investors often fail to make data-based decisions due to a lack of time and knowledge. We lower the hurdles of data-based decisions by saving research time and decreasing the knowledge gap.
  • Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Show all investments...

Annie Vereecken
Angel

Annie Vereecken

Show more...

Investment focus

  • Medical, Biotechnology, Hospital
  • Seed, Series A, Funding Round
  • Belgium

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States

Robert Kopple

Show more...

Investment focus

  • FinTech, Finance, Life Science
  • Funding Round, Convertible Note
  • United States, United Kingdom

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Jan Hruska
Angel

Jan Hruska

Show more...

Investment focus

  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Software, Gaming, Information Technology
  • Seed, Series A, Funding Round
  • United States, Denmark, Finland

Portfolio highlights

  • IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
  • Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

Carsten Maschmeyer
Angel · Hanover, Niedersachsen, Germany

Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.

Show more...

Investment focus

  • Software, Information Technology, Apps
  • Seed, Angel, Series A
  • Germany, Austria, Switzerland

Portfolio highlights

  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
  • Bildungs urlauber — The goal of Bildungsurlauber.de is to make complicated topics simple. First and foremost, we assist you in locating the appropriate seminar for you by using simple filter options - regardless of whatever federal state you work in.
Show all investments...

Ed Parkinson
Angel

Ed Parkinson

Show more...

Investment focus

  • Software, Health Care, Life Science
  • Seed
  • United Kingdom

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Biotechnology, Health Care, Life Science
  • Series A, Series B, Funding Round
  • Belgium

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Nico Wittenborn
Angel · New York, New York, United States

Nico Wittenborn is an Investor at Adjacent.

Show more...

Investment focus

  • Software, Apps, Wellness
  • Seed, Series A, Series B
  • United States, Germany, France

Portfolio highlights

  • Niantic — Niantic’s mission is to use emerging technology to enrich our experiences as human beings in the physical world. We seek to build products that inspire movement, exploration, and face-to-face social interaction. Originally formed at Google in 2010, we are now an independent company with a strong group of investors including Nintendo, The PokémonCompany, and Alsop Louie Partners. We’re focused on building games that get people outside and exploring by enabling our players to have fun while visiting new places, learning about the world around them, and meeting new friends. We’ve launched Ingress, an immersive real-world mobile game played by millions of people; it's been downloaded more than 20 million times and is played in over 200 countries and territories worldwide. We've also developed Pokémon GO, which has broken records around the world and has been downloaded more than 750 million times in its first year.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Sunnyside — Sunnyside is the #1 alcohol moderation app helping 600,000+ people drink less through tracking, coaching, and optional naltrexone via telehealth. Start your free 15-day trial.
Show all investments...

Leena Niemistö
Angel · Helsinki, Southern Finland, Finland

Leena Niemistö

Show more...

Investment focus

  • Health Care, Software, E-Commerce
  • Seed, Funding Round, Pre-Seed
  • Finland, United States

Portfolio highlights

  • ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Mark Evans
Angel · London, England, United Kingdom

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Software, E-Commerce, Health Care
  • Series A, Seed, Series C
  • United Kingdom, United States, The Netherlands

Portfolio highlights

  • 8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
  • Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Damien Lane
Angel · London, England, United Kingdom

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • SaaS, Software, Health Care
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Ireland

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
  • IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada

Portfolio highlights

  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
  • Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Show all investments...

Holger Hübner
Angel · Hamburg, Hamburg, Germany

Holger Hübner

Show more...

Investment focus

  • B2B, SaaS, Audio
  • Seed, Pre-Seed
  • Germany

Portfolio highlights

  • musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Show all investments...

Sylvain Zimmer
Angel · Paris, Ile-de-France, France

Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.

Show more...

Investment focus

  • Software, SaaS, Food and Beverage
  • Seed, Pre-Seed, Angel
  • France, United States, United Kingdom

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

Bas Godska
Angel · Amsterdam, Noord-Holland, The Netherlands

Founder Acrobator Ventures, Tech Investment Fund. Founder Acrobator.com, growth hack and marketing advisory firm. Co-Founder Netherlands for Ukraine Foundation (NL4UA.org) supporting Ukrainians affected by the war since 2022. Digital Dutchman, entrepreneur-turned-investor. eCommerce expert, growth hacker and marketeer since 2000. Assisted 100+companies worldwide as CMO, MD, board advisor, consultant. Ranked #1 Foreign Angel Investor in Russia (EWDN); Top 10 Angel Investor (Firrma.ru/SLON), Crunchbase: #1 Dutch (2019) & Top 50 EU angel investor. Techcrunch / Crunchbase: "Bas Godska is one of the most prolific Western investors in Eastern Europe." Bas' Angel Fund (>EUR 100mn AUM) ranked by PitchBook as #2 in success by IRR (2021). Top 50 SuperAngel worldwide (Arete Index, 2024-25)Roles Europe/Russia/CIS (2003-2019): CMO lastminute.com ; Country Manager Sportingbet ; CMO Europe Ebookers.com / Orbitz.com ; MD Gogol Media. CMO / dep. CEO Ozon.ru ; VP Marketing Gloria Jeans ; CMO Lamoda.ru (Rocket Internet) ; CMO Digital KupiVIP.ru ; eCommerce Director a.i. Enter | Svyaznoi ; MD myThings.com ; Guest Lecturer Digital Marketing at Skolkovo MSM MBA (2013), Guest lecturer Stanford IGC Exec MBAAngel investor in decacorn Miro, Harver (exit to Rubicon PE), Chocofamily, Piano. Bas' angel investments (~50) have helped founders raise over $1 billion from investors like Iconiq, Accel, Insight, Salesforce, Google, YC, and Techstars. The combined market cap of these companies, based on their latest funding rounds, is ~$20 billion. As a VC/LP Bas invested in 400+ companies including 20+ unicorns.

Show more...

Investment focus

  • Software, E-Commerce, Artificial Intelligence
  • Pre-Seed, Seed, Angel
  • United States, The Netherlands, Kazakhstan

Portfolio highlights

  • D2X Group — Trade digital asset options and futures on the EU-regulated market infrastructure for institutions.
  • SuperWorld — The Virtual World mapped on top of the real world to create, discover and monetize content.
  • Knowledge Gate Group — Connect with global experts in life sciences and accelerate your innovation pipeline with AI-assisted insights.
Show all investments...

Nikolaus Sturm
Angel

Nikolaus Sturm

Show more...

Investment focus

  • Life Science, Biotechnology
  • Seed
  • Germany

Portfolio highlights

  • DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Show all investments...

Christophe Ricard
Angel · Geneva, Geneve, Switzerland · 1 investment in the past 12 months

Christophe Ricard CEO of OM Pharma

Show more...

Investment focus

  • Life Science, Biotechnology, Medical Device
  • Seed, Series B
  • France

Portfolio highlights

  • Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.
Show all investments...

Virginie Saverys
Angel · 1 investment in the past 12 months

Virginie Saverys is a entrepreneur.

Show more...

Investment focus

  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Jens Mogensen
Angel · 1 investment in the past 12 months

Jens Mogensen is an Angel Investor.

Show more...

Investment focus

  • Medical, Life Science, Biotechnology
  • Series A
  • Sweden

Portfolio highlights

  • Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Show all investments...

Mariliis Holm
Angel · Research Triangle, North Carolina, United States

I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.

Show more...

Investment focus

  • Food Processing, Seafood, Wellness
  • Pre-Seed, Angel
  • Spain, Iceland, United States

Portfolio highlights

  • Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
  • Sobo Foods — Sobo Foods is a plant based comfort food provider.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Show all investments...

Steen Riisgaard
Angel · 1 investment in the past 12 months

Steen Riisgaard

Show more...

Investment focus

  • Life Science, Therapeutics, Biotechnology
  • Pre-Seed
  • Denmark

Portfolio highlights

  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Jon Oringer
Angel · Miami, Florida, United States

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, France, United Kingdom

Portfolio highlights

  • BRXS — Real Estate investing
  • Mietz — The first fully automized all-in-one renting platform for tenants and landlords.
  • OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 12 investments in the past 12 months

Nadav Ben-Chanoch - Partner @ Pareto Holdings

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France

Portfolio highlights

  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Show all investments...

Griet Nuytinck
Angel · 1 investment in the past 12 months

Griet Nuytinck is founder of Anacura.

Show more...

Investment focus

  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

John Bethell
Angel · Barcelona, Catalonia, Spain

Originally studying medicine in Scotland, John is a pioneer of the Australasian medical recruitment industry and has over 20 years of experience growing his award-winning business, Wavelength International, from two founders to over 100 staff. Moving to Europe in 2012, John worked initially for an equity crowdfunding business focused on raisingseed funds for European life sciences start-ups, before launching the Luka Global Group, including LUKA BIO, with the co-founders in 2019. John provides guidance and mentorship to start-up founders on how to set up their own in-house recruitment capabilities in preparation for growth. His recruitment portfolio includes C-suite, medical and research roles within life sciences.

Show more...

Investment focus

  • FinTech, Medical, Life Science
  • Debt Financing
  • Spain

Portfolio highlights

  • Capital Cell — Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show all investments...

Jacques Lewiner
Angel · 1 investment in the past 12 months

Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Seed, Series C
  • France

Portfolio highlights

  • Cytoo — CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening.They develop, manufacture, and distribute products that make cellular analysis robust and reliable by dramatically decreasing cell variability.There new micropattern-based products aredesigned to meet the needs of all clients whatever their research goals. They are open to suggestions or specific requests that can improve and spread the scope of this breakthrough in quantitative cell analysis.
  • Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Show all investments...

Ritu Bansal-Mutalik
Angel · San Francisco Bay Area, California, United States

Ritu Bansal-Mutalik is a Senior Director, Process Research and Development at ZymoChem.

Show more...

Investment focus

  • Wellness, Life Science, Biotechnology
  • Seed
  • Spain

Portfolio highlights

  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Show all investments...

Maximilien Levesque
Angel · Paris, Ile-de-France, France

Maximilien Levesque - CEO and co-founder @ AQEMIA

Show more...

Investment focus

  • Life Science, Biotechnology
  • Seed
  • United Kingdom

Portfolio highlights

  • CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Show all investments...

Naheed Kurji
Angel · Toronto, Ontario, Canada · 1 investment in the past 12 months

Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica provides the pharmaceutical industry with an integrated, holistic, and end-to-end enabling platform that enhances how scientists design, screen,and personalize medicines for patients, and has recently been named by Deep Knowledge Analytics as one of the top 20 AI in Pharma companies globally. Naheed is passionate about how people interact with technology to make more informed and faster decisions, and is dedicated to advancing the responsible application of AI to healthcare problems. At Cyclica, he focuses on strategy and corporate development activities to affect change in the pharmaceutical industry, and strives to foster an environment where his team can solve the biggest challenges in human health through groundbreaking innovation. Naheed is a co-founder of The Alliance for Artificial Intelligence in Healthcare (AAIH), of which Naheed is 1 of 4 appointed Executive Officers. Naheed is an experienced professional specialized in strategic planning, corporate finance and entrepreneurship, having received an MBA from the University of Toronto, Rotman School of Management, and a Certificate from MIT on Artificial Intelligence and the Implication on Business Strategy. He has been featured in the Globe and Mail, CBC, Forbes, Vanity Fair, StartUp Health Magazine, WuXi Insider Perspective, and VentureBeat. Naheed is also a guest lecturer at various universities globally on the topic of entrepreneurship and AI in medicine.

Show more...

Investment focus

  • Life Science, Biotechnology
  • Seed
  • United Kingdom

Portfolio highlights

  • CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Show all investments...

Simon Galbraith
Angel · Cambridge, Cambridgeshire, United Kingdom

Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.

Show more...

Investment focus

  • Software, Health Care, Life Science
  • Pre-Seed, Funding Round
  • Croatia, United Kingdom

Portfolio highlights

  • BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
  • SysKit — Syskit Point is your go-to platform for governing the entire M365 lifecycle. Reporting, auditing, and governance - simplified. Start your 21-day free trial.
Show all investments...

Toni Kroos
Angel

Toni Kroos is a German professional footballer who plays as a midfielder for La Liga club Real Madrid.

Show more...

Investment focus

  • Health Care, Rental, Fitness
  • Seed, Pre-Seed, Funding Round
  • Germany

Portfolio highlights

  • DUKE — Duke is a technology company that operates a real time car logistics system. Our Mission is to provide an insane customer experience for car rental. Duke offers on demand rental cars through a 24/7 delivery service.
  • rebirth:active — rebirth: active is an evidence-based, individual health solution that provides your employees with the tools they need to improve their overall health and well-being.
  • HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Show all investments...

Josefin Landgård
Angel · Stockholm, Stockholms Lan, Sweden

Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.

Show more...

Investment focus

  • Health Care, Medical, Women's
  • Seed, Angel, Pre-Seed
  • Sweden, France

Portfolio highlights

  • Estmn — Estrid is an online portal that offers women's personal care products.
  • Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
  • Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Show all investments...

Alfons Hidalgo
Angel · 1 investment in the past 12 months

Alfons Hidalgo

Show more...

Investment focus

  • Medical, Biopharma, Life Science
  • Funding Round
  • Spain

Portfolio highlights

  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Show all investments...
Investors by industry
Investors by country
Angel Investors in Europe by industry

Contact investors today

Find who invests in your industry, stage, and country in 5 minutes.

Find investors — It's Free!